SCHEMBL7891504

SCHEMBL7891504

CC1CN(c2ccc(OCc3ccccc3)cc2)CCC1NCCCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.47
ACACB O00763 1/20 0.46
BCHE P06276 2/20 0.46
SIGMAR1 Q99720 1/20 0.44
MCHR1 Q99705 1/20 0.42
KDM4E B2RXH2 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 2/20 0.41
LTA4H P09960 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
FUCA1 P04066 2/20 0.40
HTT P42858 1/20 0.40
SLC2A1 P11166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7891487 0.87 MCHR1 (0.47) MCHR1KDM4EKMT2ASMN1; SMN2ALDH1A1
SCHEMBL27546385 0.81 EPHX2 (0.54) ACACBKDM4EKMT2AEPHX2LTA4H
SCHEMBL7899149 0.81 EPHX2 (0.54) ACACBKDM4EKMT2AEPHX2LTA4H
SCHEMBL7899607 0.80 ACACB (0.49) HRH3ACACBMCHR1KDM4ESMN1; SMN2
SCHEMBL7898015 0.79 KDM4E (0.54) HRH3BCHESIGMAR1KDM4EKMT2A
SCHEMBL7891518 0.78 BCHE (0.45) HRH3ACACBBCHESIGMAR1KDM4E
SCHEMBL7891512 0.78 BCHE (0.45) HRH3ACACBBCHESIGMAR1KDM4E
SCHEMBL5689925 0.77 BCHE (0.47) HRH3BCHESIGMAR1KDM4EKMT2A
SCHEMBL7902701 0.75 FOXM1 (0.53) HRH3BCHEKDM4EKMT2ASMN1; SMN2
SCHEMBL27473865 0.73 HRH3 (0.54) HRH3ACACBMCHR1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed